Background: A rapid increase in legislation restricting access to clinical abortion services in the US has sparked renewed interest in self-managed abortion as a response to clinic access barriers. At the same time, rising interest in self-care and the role of the internet as a go-to source of goods and services raises the possibility that ...Read more >

Background: Mifepristone did not “revolutionize” access to abortion in the ways originally anticipated. However, in the 17 years since its approval it has changed the face of abortion care, potentially in ways that have increased access. In 2014, nearly-one third of abortions were early medication procedures, and 26% of clinic facilities provided only early medication ...Read more >

Background: The Mifeprex® Risk Evaluation and Mitigation Strategy (REMS) requires that the drug be dispensed only in a clinic, office, or hospital, despite the lack of evidence that this improves safety. In a recent survey of obstetrician-gynecologists (Ob-Gyns), we found that only 14% provided medication abortion, but an additional 15% said they would provide it ...Read more >